Update: Raccoon Rabies Epizootic —

United States, 1996

Raccoon Rabies Epizootic — Continued Since 1960, rabies has been reported more frequently in wild animals than in domestic animals in the United States. In 1995, wildlife rabies accounted for 92% of animal rabies cases reported to CDC; approximately 50% of these cases (3964 of

7881 total cases) were associated with raccoons (1 ). This report describes the continuing spread of an epizootic of raccoon rabies in affected mid-Atlantic and northeastern states and the spread into Ohio, indicating an increasing move westward

despite geographic barriers.

New York. Rabies was first confirmed in raccoons in New York in May 1990; since

then, 7851 cases of animal rabies (6637 in raccoons and 1214 in domestic and other

wild animals infected with the raccoon rabies virus variant) have been confirmed from

all 62 counties in the state. Since 1990, the raccoon rabies epizootic has spread steadily northward within the state at an average rate of 25 miles per year. During 1994–

1995, however, a focus of raccoon rabies re-emerged in the 11 counties that were

affected first by the epizootic during 1990–1991: from 1994 through 1995, the total

number of raccoon rabies cases in these 11 counties increased 245% (from 40 to 138,

respectively). Cases of rabies in domestic animals also have increased substantially:

during 1990–1995, a total of 158 cases were confirmed in cats, and 36 cases were

confirmed in dogs. Before 1990, postexposure prophylaxis (PEP) was provided to an

average of <100 persons annually in New York; in comparison, during 1990–1995, approximately 10,000 persons received PEP.

North Carolina. Rabies was first confirmed in raccoons in the northeastern part of

the state during 1991, probably reflecting an extension of the mid-Atlantic raccoon

rabies epizootic. During 1992, cases were confirmed in raccoons in the southeastern

quadrant of the state. Both epizootic foci continued to spread, and by late 1994 and

early 1995, cases were confirmed in the central section of the state. In 1995, of the

875 raccoons submitted for testing, 362 (41%) were positive for rabies, more than double the number of raccoon rabies cases reported in the state in 1994 (143 cases).

Vermont. Rabies was first confirmed in foxes in northwestern Vermont in February

1992 and in raccoons in southwestern Vermont in June 1994. The raccoon rabies epizootic has continued to spread northward up the Champlain basin and the Connecticut

River valley; in 1995, cases were detected in all 14 counties within the state. In 1995, of

685 animals tested for rabies, 179 (26%) were positive, a 20% increase from 1994. In

TM

January 3, 1997 / Vol. 45 / Nos. 51 & 52

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES / Public Health Service

1117 Update: Raccoon Rabies 

Epizootic — United States, 1996

1120 Children with Elevated Blood Lead

Levels Attributed to Home

Renovation and Remodeling

Activities — New York, 1993–1994

1123 Abortion Surveillance: Preliminary

Data — United States, 1994

1128 Notices to Readers 
1995, of the 261 raccoons tested for rabies, 104 (40%) were positive; in addition, testing was positive for 31 foxes, 38 skunks, two woodchucks, one pig, one beaver, and

one cat.

Rhode Island. Rabies was first confirmed in January 1994 in raccoons in Rhode

Island near the state’s northern border. In 1994, animal rabies cases were reported

from 23 (59%) of 39 cities and towns, and by 1995, cases had been confirmed in every

city and town except for the island communities of New Shoreham and Jamestown.

In 1995, of 886 animals tested for rabies, 324 (37%) were positive, an 11% increase

from 1994 in the proportion of all animals testing positive. In 1995, of 345 raccoons

tested for rabies, 215 (62%) were positive; in addition, testing was positive for

83 skunks, nine foxes, seven cats, four cows, and one woodchuck.

Maine. Rabies was first confirmed in raccoons in southern Maine and in foxes in

central Maine in August 1994. Subsequently, cases have been detected in both domestic and wild animals in nine (56%) of 16 counties and 77 (17%) of 456 cities and

towns in the state. From 1994 through 1995, the number of animals submitted for

rabies testing increased from 351 to 736, and the number of confirmed animal rabies

cases increased 10-fold, from 10 to 101. In 1995, of 117 raccoons tested for rabies,

41 (35%) were positive; in addition, testing was positive for 44 skunks, seven foxes,

and one dog.

Ohio. In late May 1996, the first indigenous case of raccoon rabies in Ohio was

confirmed in a racoon captured in the village of Poland in northeastern Ohio, approximately 3 miles west of the Pennsylvania border. In June 1996, active surveillance of

dead animals found on roads and nuisance animals reported to animal-control agencies was initiated within a 10-mile radius of the index case; however, no cases were

confirmed among the 57 specimens tested. Active surveillance continues in this region.

Reported by: TK Lee, DrPH, KF Gensheimer, MD, State Epidemiologist, Maine Dept of Human

Svcs. RH Johnson, DVM, Vermont Dept of Health. U Bandy, MD, State Epidemiologist, State of

Rhode Island and Providence Plantations Dept of Health. CA Hanlon, VMD, CV Trimarchi,

D Morse, MD, State Epidemiologist, New York State Dept of Health. JL Hunter, DVM, JM Moser,

MD, State Epidemiologist, North Carolina Dept of Environment, Health, and Natural Resources.

KA Smith, DVM, TJ Halpin, MD, State Epidemiologist, Ohio Dept of Health. Viral and Rickettsial

Zoonoses Br, Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC.

Editorial Note: The variant of rabies virus associated with raccoons has been present

in the southeastern United States since the 1950s and was introduced into the midAtlantic region of the United States in the mid-1970s, probably as the result of translocation of animals from the southeastern United States (2 ). The first such case was

reported from West Virginia in 1977. Infected raccoons subsequently were reported

from Virginia (1978), Maryland (1981), the District of Columbia (1982), Pennsylvania

(1982), Delaware (1987), New Jersey (1989), New York (1990), Connecticut (1991),

North Carolina (1991), Massachusetts (1992), New Hampshire (1992), Rhode Island

(1994), Vermont (1994), Maine (1994), and Ohio (1996) (Figure 1). During 1995, states

in the mid-Atlantic and Northeast regions accounted for 89% (3510 of 3964) of the

reported cases of raccoon rabies in the United States (1 ). The rapidity of spread

throughout the mid-Atlantic region may reflect the density of raccoon populations associated with abundant food supplies and denning sites in urban and suburban areas

(3 ). Although westward progression of the epizootic has been slowed by geographic

barriers such as the Great Lakes, the Chesapeake Bay, the Potomac and Susquehanna

1118 MMWR January 3, 1997

Raccoon Rabies Epizootic — Continued
rivers, and the Appalachian Mountains (4 ), once rabies infection becomes established

in racoons in the Ohio Valley, the epizootic may spread more rapidly across the Midwest.

There have been no documented human rabies cases in the United States associated with the raccoon rabies virus variant. Potential explanations for this are that first,

because raccoons are large and bites to humans are likely to be recognized, rabies PEP

can be administered rapidly, and second, domestic animal rabies vaccination programs have provided a barrier to infection of humans by eliminating a potential link in

rabies transmission from wildlife to humans. This barrier should be maintained also

through traditional public health measures such as educating the public about the

importance of rabies vaccination for pets, mandatory vaccination and leash laws, and

animal-control programs.

The costs associated with rabies control and prevention in the northeastern United

States have increased in direct relation to the spread of the raccoon rabies epizootic;

these costs primarily reflect the number of PEP regimens administered. For example,

in Connecticut, the estimated number of persons to whom PEP was administered increased from 41 in 1990 to 887 during the first 9 months of 1994 as the raccoon rabies

epizootic spread statewide, at a median cost of $1500 per person exposed (5 ). Rabies

control in two counties in New Jersey accounted for a cost increase of $1.2 million

from 1988 (before the introduction of the raccoon rabies epizootic) through 1990 (the

year the epizootic became established) (6 ).

1985-1989

1990-1993

1980-1984

1977-1979

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA AAAA

AAAAAAAAAA

AAAAAAAAAAAAAA

AAAAAAAAAAAAAA

AAAA

AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA

Pa.

W.V.

Va.

N.C.

N.Y.

Vt.

N.H.

Me.

Md.

Del.

N.J.

R.I.

AAAA AAAA AAAA AAAA AAAAA

A

A

A

A

AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA AAAA AAAA AAAA

AAAA AAAA

A

A

A

A

A

A

Ohio

Mass.

Conn.

1994-1996

AAAA AAAA AAAA AAAA

AAAA AAAA

AAAA

AAAA

No Raccoon Rabies

Detected

FIGURE 1. Detection of raccoon rabies, by year — United States, 1996

Vol. 45 / Nos. 51 & 52 MMWR 1119

Raccoon Rabies Epizootic — Continued
New methods for slowing or containing the raccoon rabies epizootic are being considered in several states. For example, oral vaccination control programs using

vaccinia-rabies glycoprotein recombinant vaccine contained within baits have been

implemented in trials conducted in Cape May, New Jersey; Cape Cod, Massachusetts;

eastern and northern New York state; and Pinellas County, Florida (7 ). Implementation

of such programs to prevent spread of raccoon rabies to new areas is an adjunct to

traditional control methods.

References

1. Krebs JW, Strine TW, Smith JS, Noah DL, Rupprecht CE, Childs JE. Rabies surveillance in the

United States during 1995. J Am Vet Med Assoc 1996;204:2031–44.

2. Nettles VF, Shaddock JH, Sikes RK, Reyes CR. Rabies in translocated raccoons. Am J Public

Health 1979;69:601–2.

3. Anthony JA, Childs JE, Glass GE, Korch GW, Ross L, Grigor JK. Land use associations and

changes in population indices of urban raccoons during a rabies epizootic. J Wildl Dis

1990;26:170–9.

4. Rupprecht CE, Smith JS. Raccoon rabies: the re-emergence of an epizootic in a densely populated area. Seminars in Virology 1994;5:155–264.

5. CDC. Rabies postexposure prophylaxis—Connecticut, 1990–1994. MMWR 1996;45:232–4.

6. Uhaa IJ, Dato VM, Sorhage FE, et al. Benefits and costs of using an orally absorbed vaccine

to control rabies in raccoons. J Am Vet Med Assoc 1992;201:1873–82.

7. Rupprecht CE, Hanlon CA, Niezgoda M, Buchanan JR, Diehl D, Koprowski H. Recombinant

rabies vaccines: efficacy assessment in free-ranging animals. Onderstepoort J Vet Res

1993;60:463–8.

 Raccoon Rabies Epizootic — Continued

Children with Elevated Blood Lead Levels

Attributed to Home Renovation and Remodeling Activities —

New York, 1993–1994

Elevated Blood Lead Levels — Conti Renovation and remodeling activities that disturb lead-based paint can create sub- nued

stantial amounts of lead dust in the home; such dust can then be inhaled or ingested

by children (1 ). In January 1995, the New York State Department of Health (NYSDOH)

assessed lead exposure among children resulting from home renovation and remodeling during 1993–1994. This report summarizes findings of the study, which identified

320 children in New York state (excluding New York City) with blood lead levels (BLLs)

≥20 μg/dL that were considered to be attributable to residential renovation and remodeling.

In December 1993, New York enacted a state law requiring that all children undergo

blood lead screening at ages 1 and 2 years; however, some children are not screened.

For children with confirmed elevated BLLs or evidence of high-dose lead exposures,

BLL testing is required through age 6 years. For some children aged >6 years, BLLs are

tested when there are symptoms of lead poisoning or when there is another reason to

suspect lead exposure. All BLL results must be reported to NYSDOH by laboratories

performing these tests, which provides results for children aged ≤14 years to respective local health departments. Local health departments then are responsible for environmental investigation and follow-up of children aged <6 years with BLLs ≥20 μg/dL.

During 1993–1994, a total of 4608 children with venous BLLs ≥20 μg/dL in New York

were reported to local health departments. In January 1995, environmental health and

1120 MMWR January 3, 1997

 Raccoon Rabies Epizootic — Continued
nursing staff of the local health departments reviewed the case records of these children to identify those who within the previous year had been exposed to residential

renovation or remodeling activities that involved disturbing lead-based paint and for

whom another likely source of lead exposure could not be identified. Disturbed paint

was presumed to have been lead-based if lead was found in similar paint that remained in the home. For each case, data abstracted included 1) child’s birth date,

2) blood test date, 3) BLL, 4) address of the dwelling, 5) method used to remove old

paint, and 6) identity of the person who performed the paint removal. Dwellings were

classified as being in rural, suburban, or urban areas based on the average number of

persons per square mile residing within the census block (rural: 0–2000 persons; suburban: 2001–15,000; and urban: ≥15,001) (2 ).

Review of records for 1993–1994 identified 320 (6.9%) children in 258 households

with elevated BLLs considered to be attributable to renovation and remodeling. Age

was known for 289 children; of these, 29 (10%) were aged <1 year; 92 (32%), aged 1

year; 71 (25%), aged 2 years; 37 (13%), aged 3 years; 41 (14%), aged 4 years; 10 (3%),

aged 5 years; and nine (3%), aged 6–10 years. BLLs were 20–24 μg/dL in 117 (37%)

children, 25–29 μg/dL in 76 (24%), 30–39 μg/dL in 87 (27%), 40–59 μg/dL in 32 (10%),

60–79 in seven (2%), and ≥80 μg/dL in one (<1%). Area of residence was known for 281

children; 120 (43%) resided in suburban areas, 101 (36%) in rural areas, and 60 (21%)

in urban areas.

For 150 children, more than one type of paint removal activity was reported. Removal activities included scraping (150 reports), sanding (137), chemical stripping

(62), using hand-held heat guns (28), using blow torches (nine), and blasting with

either water or an abrasive material (six). There were 88 reports of complete removal

of a painted component (e.g., wall, window, or stair). Information about who performed paint removal was known for 302 children; work was performed by a resident

owner or tenant (187 [62%] children), by a nonresident owner (66 [22%] children), by

a contractor (42 [14%] children), or by a nonprofessional employee (seven [2%] children).

Reported by: EM Franko, MS, WN Stasiuk, PhD, RW Svenson, MPA, New York State Dept of

Health. Lead Poisoning Prevention Br, Div of Environmental Hazards and Health Effects, National

Center for Environmental Health, CDC.

Editorial Note: Childhood lead exposure is a preventable environmental health problem that usually occurs in residential settings (3 ). In the United States, an estimated

1.7 million children aged <6 years have BLLs ≥10 μg/dL and approximately 200,000

have BLLs ≥20 μg/dL (4 ). BLLs at least as low as 10 μg/dL are associated with adverse

effects on children’s behavior and development (3 ). CDC has recommended 1) nutritional and educational interventions for children identified with BLLs 10–19 μg/dL,

2) environmental evaluation to identify lead hazards for children with BLLs ≥20 μg/dL

or with BLLs that persist at ≥15 μg/dL, and 3) medical evaluation and intervention for

children with BLLs ≥20 μg/dL (3 ).

The findings in this report suggest that home renovation and remodeling was an

important source of lead exposure among children in New York during 1993–1994.

Although some of the 320 children may have been exposed to sources of lead other

than or in addition to renovation and remodeling, this assessment probably underestimates the burden of lead exposure associated with renovation and remodeling in

New York for at least four reasons. First, children with elevated BLLs <20 μg/dL were

Vol. 45 / Nos. 51 & 52 MMWR 1121

Elevated Blood Lead Levels — Continued
not included in this study. Second, many children who were exposed to lead during

home renovation or remodeling may not have had BLL testing both because universal

screening was not a legal requirement until December 1993 and because screening

rates were low among children aged >2 years and among those who did not live in

urban areas. Third, some laboratories may have incompletely reported children with

BLLs ≥20 μg/dL. Finally, information on renovation and remodeling was not routinely

collected during environmental investigations before this study; as a result, some children with these exposures may not have been identified in their case records.

In 1978, the Consumer Product Safety Commission banned manufacture and use of

paint containing >0.06% lead by weight for interior and exterior residential surfaces,

toys, and furniture. Because the concentration of lead in paint steadily declined before

1978 (5 ), older homes are more likely to have paint with higher concentrations of lead.

The risk for lead exposure associated with this source is greatest in homes built before

1950 (6 ); in New York, both the number (3,401,416) and proportion (47%) of housing

units built before 1950 are greater than in any other state (7 ).

Children can be exposed to lead-based paint in housing if the paint is in a form that

can be inhaled or ingested (e.g., chipping, peeling, or pulverized to dust). Renovation

and remodeling may generate lead dust and fumes. In this analysis, paint removal in

most (86%) cases was performed by persons who were not professional contractors

and who may have been unaware of lead hazards and protective measures for safely

containing dust and paint chips. Their work primarily involved sanding and scraping,

methods that are potentially hazardous but require no training and little financial investment (1 ).

Persons who remove lead-based paint from dwellings should follow the recommendations of the U.S. Department of Housing and Urban Development and the U.S.

Environmental Protection Agency for minimizing lead exposure (1,8 ). These include

1) relocating occupants during paint removal and prohibiting children and pregnant

women from entering the work area; 2) isolating areas where work is being performed

from other areas of the house and avoiding practices that create lead dust or fumes;

3) performing a full clean-up after work is completed; and 4) considering the monitoring of BLLs in persons who live or work in the dwelling.

Although children residing in poverty and in urban areas are at the highest risk for

lead exposure (4 ), 79% of the children identified in this study resided in suburban or

rural settings. This finding underscores that in all communities with older housing,

appropriate actions include public education about lead hazards, provider-based anticipatory guidance about lead hazards, and BLL screening of children.

As a result of this investigation, local health departments in New York now routinely collect information about renovation and remodeling when investigating the

home environments of children with elevated BLLs. Information about this potential

source of lead exposure will be reported to NYSDOH, which will use these data to

monitor trends in causes of childhood lead poisoning and identify areas to be targeted

for educational outreach activities.

References

1. Office of Lead-Based Paint Abatement and Poisoning Prevention. Guidelines for the evaluation

and control of lead-based paint hazards in housing. Washington, DC: US Department of Housing and Urban Development, Office of Lead-Based Paint Abatement and Poisoning Prevention,

1995.

1122 MMWR January 3, 1997

Elevated Blood Lead Levels — Continued
2. Bureau of the Census. 1990 Census of population and housing: summary tape file 1B. Washington, DC: US Department of Commerce, Economics and Statistics Administration, Bureau

of the Census, 1991.

3. CDC. Preventing lead poisoning in young children: a statement by the Centers for Disease

Control. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service,

1991.

4. Brody DJ, Pirkle JL, Kramer RA, et al. Blood lead levels in the U.S. population: phase 1 of

the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA

1994;272:277–83. 

5. Office of Policy Development and Research. Comprehensive and workable plan for the abatement of lead-based paint in privately owned housing: report to Congress. Washington, DC:

US Department of Housing and Urban Development, Office of Policy Development and Research, 1991; report no. HUD-PDR-1295(1).

6. Lead-Based Paint Hazard Reduction and Financing Task Force. Putting the pieces together: controlling lead hazards in the nation’s housing. Washington, DC: US Department of Housing and

Urban Development, Lead-Based Paint Hazard Reduction and Financing Task Force, 1995; report no. HUD-1547-LBP.

7. Bureau of the Census. 1990 Census of housing: detailed housing characteristics, United States.

1990 CH-2-1. 1993. World-Wide Web site http://venus.census.gov/cdrom/lookup/CMD=LIST/

DB=C90STF3A/LEV=STATE, Table H-25. Accessed September 10, 1996.

8. Office of Pollution Prevention and Toxics. Reducing lead hazards when remodeling your home.

Washington, DC: US Environmental Protection Agency, Office of Pollution Prevention and Toxics, 1994; report no. EPA-747-R-94-002.

Elevated Blood Lead Levels — Continued

Abortion Surveillance: Preliminary Data —

United States, 1994

Abortion Surveillance — Continued For 1994, CDC received data on legal induced abortions from the 50 states, New

York City, and the District of Columbia. This report presents preliminary data for 1994.

Final abortion data for 1993 and 1994 will be published during spring 1997.

In 1994, a total of 1,267,415 legal induced abortions were reported to CDC (Table 1),

a decrease of 4.7% from the number reported for 1993 (1 ). The number of live births

decreased by 1.1% over the same period (2 ). Fewer abortions were reported from

43 of the 52 reporting areas in 1994 than during the previous year. The national abortion ratio (number of legal abortions per 1000 live births) decreased from 334 in 1993

to 321 in 1994 (Table 1, Figure 1), and the national abortion rate (number of legal abortions per 1000 women aged 15–44 years) decreased from 22 to 21. Consistent with

previous years, approximately 92% of women who had a legal abortion were residents of the state in which the procedure was performed.

Women who obtained legal abortions in 1994 were predominately aged <25 years,

white, and unmarried. As in 1993, approximately one fifth of women who obtained a

legal abortion in 1994 were adolescents (aged ≤19 years). Curettage (suction and

sharp) remained the primary abortion procedure, accounting for 99% of all procedures. As in previous years, approximately 54% of legal abortions were performed

during the first 8 weeks of gestation; specifically, 15.7% were at ≤6 weeks, 16.5% at

7 weeks, and 21.6% at 8 weeks. Approximately 88% of abortions were performed during the first 12 weeks of pregnancy.

Reported by: Statistics and Computer Resources Br, Div of Reproductive Health, National Center

for Chronic Disease Prevention and Health Promotion, CDC.

Vol. 45 / Nos. 51 & 52 MMWR 1123

Elevated Blood Lead Levels — Continued
TABLE 1. Reported number of legal induced abortions, abortion ratios,* abortion rates,† and characteristics 

obtained legal induced abortions, by year — United States, selected years, 1972–1994 Characteristic 1972 1976 1980 1985 1990 1991 1992 1993

Reported no. legal abortions 586,760 988,267 1,297,606 1,328,570 1,429,577 1,388,937 1,359,145 1,330,4Abortion ratio 180 312 359 354 345 339 335 334 Abortion rate 13 21 25 24 24 24 23 22 

Percentage distribution** Residence In-state 56.2 90.0 92.6 92.4 91.8 91.6 92.0 91.4 

Out-of-state 43.8 10.0 7.4 7.6 8.2 8.4 8.0 8.6 

Age group (yrs)

≤19 32.6 32.1 29.2 26.3 22.4 21.0 20.1 20.0 

20–24 32.5 33.3 35.5 34.7 33.2 34.4 34.5 34.4 

≥25 34.9 34.6 35.3 39.0 44.4 44.6 45.4 45.6 

Race

White 77.0 66.6 69.9 66.6 64.8 63.8 61.5 60.9 Black 23.0 33.4 30.1 29.8 31.8 32.5 33.9 34.9 Other†† — — — 3.5 3.4 3.7 4.6 4.2 

Ethnicity

Hispanic — — — — 9.8 13.5 15.2 14.7 Non-Hispanic — — — — 90.2 86.5 84.8 85.3 

Marital status

Married 29.7 24.6 23.1 19.3 21.7 21.4 20.8 20.4 Unmarried 70.3 75.4 76.9 80.7 78.3 78.6 79.2 79.6 

No. live births§§

 0 49.4 47.7 58.4 56.3 49.2 47.8 45.9 46.3  1 18.2 20.7 19.4 21.6 24.4 25.3 25.9 26.0  2 13.3 15.4 13.7 14.5 16.9 17.4 18.0 17.8  3 8.7 8.3 5.3 5.1 6.1 6.4 6.7 6.6 ≥4 10.4 7.9 3.2 2.5 3.4 3.4 3.5 3.3 
Type of procedure Curettage 88.6 92.8 95.5 97.5 98.8 98.9 98.9 99.1 

 Suction 65.2 82.6 89.8 94.6 96.0 97.3 97.0 94.8  Sharp 23.4 10.2 5.7 2.9 2.8 1.6 1.9 4.3 Intrauterine instillation 10.4 6.0 3.1 1.7 0.8 0.7 0.7 0.6 Other¶¶ 1.0 1.2 1.4 0.8 0.4 0.4 0.4 0.3 

Weeks of gestation

≤8 34.0 47.0 51.7 50.3 51.6 52.3 52.1 52.3 

≤6 — — — — — — 14.3*** 14.7

 7 — — — — — — 15.6*** 16.2 8 — — — — — — 22.2*** 21.6 9–10 30.7 28.1 26.2 26.6 25.3 25.1 24.2 24.4 11–12 17.5 14.4 12.2 12.5 11.7 11.5 12.0 11.6 13–15 8.4 4.5 5.1 5.9 6.4 6.1 6.0 6.3 16–20 8.2 5.1 3.9 3.9 4.0 3.9 4.2 4.1 

≥21 1.2 0.9 0.9 0.8 1.0 1.1 1.5 1.3 

 *Number of legal induced abortions per 1000 live births. † Number of legal induced abortions per 1000 women aged 15–44 years.

§ Updated preliminary data. The number of areas reporting a given characteristic varied. For 1993, the number of 

residence was 43; age, 44; race, 36; ethnicity, 23; marital status, 37; number of live births, 39; type of procedure, 4gestation, 41. Data may differ from previously published data, due to late revisions from several reporting areas.

¶ The number of areas reporting a given characteristic varied. For 1994, the number of areas reporting residence 

race, 37; ethnicity, 23; marital status, 36; number of live births, 39; type of procedure, 41; and weeks of gestation, 

 **Percentage distributions are based on known values in data from all areas reporting a given characteristic, e

proportion of unknown values exceeded 15%. †† Reported as “other” race. §§ For years 1972 and 1976, data indicate number of living children. ¶¶ Includes hysterotomy and hysterectomy.

***Data are for 36 of 39 areas reporting weeks of gestation. ††† Data are for 38 of 41 areas reporting weeks of gestation. §§§ Data are for 38 of 40 areas reporting weeks of gestation.
Editorial Note: During 1980–1994, the annual number of legal induced abortions in the

United States varied by ≤5% (Table 1). However, since 1990 (the year in which the

number of abortions was highest), the number of reported abortions has steadily decreased. In 1994, a total of 83% of reporting areas reported fewer abortions compared

with 1993.

During 1972–1980, the national abortion rate increased each year; during 1981–

1993, the rate remained stable, fluctuating between 22 and 24 per 1000 women of

reproductive age (i.e., aged 15–44 years) (Figure 1). The 1994 rate of 21 was the lowest

rate recorded since 1976 (3 ).

In 1994, the national ratio of abortions to live births (321 abortions per 1000 live

births) was lower than for any year since 1976 (3 ). Factors that could have contributed

to this decrease in the proportion of pregnancies that ended in an abortion include

reduced access to abortion services, changes in attitudes about the decision to have

an abortion or to carry a pregnancy to term, and the possibility that the number of

unintended pregnancies has decreased (4–6 ).

The number of live births and the national fertility rate (number of live births per

1000 women of reproductive age) peaked in 1990 (Figure 1). Subsequent declines in

the annual number of abortions and live births suggest decreases in the number of

pregnancies each year in the United States. Although the actual number of women of

1972 1974 1976 1978 1980 1982 1984 1986 1988 1990 1992 1994

0

10

20

30

40

50

60

70

80

0

100

200

300

400

500

Rate

Year

Ratio

Fertility Rate

Abortion Ratio

Abortion Rate

*Live births per 1000 women aged 15–44 years.

†Number of legal induced abortions per 1000 live births.

§Number of legal induced abortions per 1000 women aged 15–44 years.

FIGURE 1. Fertility rate* and abortion ratio† and rate§, by year — United States,

1972–1994

1126 MMWR January 3, 1997

Abortion Surveillance — Continued
reproductive age has increased by 12% since 1980, the age distribution in this population has shifted toward the later, less fertile reproductive years (2 ). For example, the

proportion of women of reproductive age who were aged <30 years (the age associated with the highest fertility) declined from 58% in 1980 to 46% in 1994 (Bureau of the

Census, unpublished data, 1996), whereas women aged 35–44 years (the age associated with the lowest fertility) accounted for 25% of reproductive-aged women in 1980

and 35% in 1994.

Since 1992, most reporting areas have reported abortions by weeks of gestation for

abortions performed at ≤8 weeks. Because of the emergence of medical methods for

terminating pregnancies primarily at ≤8 weeks of gestation, these data will continue to

be important for monitoring trends in legal abortions (7–10 ).

Many states emphasize the prevention of unintended pregnancy, particularly

among teenagers. During 1994, the total number of legal induced abortions was available for all 52 reporting areas; however, approximately 26% of abortions were reported from states without centralized reporting, and these states could not provide

information about characteristics (e.g., age or race) of women obtaining legal abortions. To assist efforts to prevent unintended pregnancy, each state needs an accurate

assessment of abortion on an ongoing basis (including the number and characteristics

of women obtaining legal abortions).

Additional statistical and epidemiologic information on legal induced abortions is

available from CDC’s automated Reproductive Health Information line, (404) 330-1230,

which provides information by fax, by voice recordings, or through the mail.

References

 1. CDC. Abortion surveillance: preliminary data—United States, 1993. MMWR 1996;45:235–8.

 2. NCHS. Advance report of final natality statistics, 1994. Hyattsville, Maryland: US Department

of Health and Human Services, Public Health Service, CDC, 1996; DHHS publication no.

(PHS)96-1120. (Monthly vital statistics report; vol 44, no. 11, suppl).

 3. CDC. Abortion surveillance, 1976. Atlanta: US Department of Health and Human Services,

Public Health Service, CDC, 1978.

 4. Council on Scientific Affairs, American Medical Association. Induced termination of pregnancy

before and after Roe v. Wade: trends in the mortality and morbidity of women. JAMA

1992;268:3231–9.

 5. Henshaw SK. The accessibility of abortion services in the United States. Fam Plann Perspect

1991;23:246–52,263.

 6. Henshaw SK, VanVort J. Abortion services in the United States, 1991 and 1992. Fam Plann

Perspect 1994;26:100–6,112.

 7. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU

486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509–13.

 8. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect

1995;27:142–8,185.

 9. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med

1995;333:537–40.

10. Creinin MD, Vittinghoff E, Galbraith S, Klaisle C. A randomized trial comparing misoprostol

three and seven days after methotrexate for early abortion. Am J Obstet Gynecol

1995:173:1578–84.

Abortion Surveillance — Continued

Vol. 45 / Nos. 51 & 52 MMWR 1127

Abortion Surveillance — Continued
Notice to Readers

Satellite Videoconference

on Epidemiology and Vaccine-Preventable Diseases

Epidemiology and Prevention of Vaccine-Preventable Diseases, a live satellite

videoconference, will be broadcast to sites nationwide from noon to 3:30 p.m. eastern

standard time on February 20, February 27, March 6, and March 13, 1997, over the

Public Health Training Network. Cosponsors are CDC, the Association of Schools of

Public Health; the University of North Carolina at Chapel Hill School of Public Health;

and the North Carolina Department of Environment, Health, and Natural Resources. 

The four-module interactive videoconference will provide information about vaccine-preventable diseases, including the changes in pertussis and poliovirus vaccine;

vaccine management and safety; and standard vaccination practices. Registration information is available from state immunization coordinators; Pam Layh, telephone

(919) 966-9136, e-mail pam_layh@unc.edu; or the World-Wide Web (includes state immunization coordinator contact information) at www.sph.unc.edu/cdlhc.

Notice to Readers

Satellite Videoconference on Pertussis and Poliovirus Vaccines

Update on Pertussis and Poliovirus Vaccines, a special segment of the Epidemiology and Prevention of Vaccine-Preventable Diseases live satellite videoconference series, will be broadcast to sites nationwide from noon to 3:30 p.m. eastern standard

time on February 27, 1997, over the Public Health Training Network. Cosponsors are

CDC, the Association of Schools of Public Health; the University of North Carolina at

Chapel Hill School of Public Health; and the North Carolina Department of Environment, Health, and Natural Resources.

The interactive conference will cover the changes in pertussis and poliovirus vaccines, including discussion of the newly licensed acellular pertussis vaccines and recommendations about the new sequential inactivated poliovirus vaccine/oral

poliovirus vaccine. Registration information is available from state immunization coordinators; Pam Layh, telephone (919) 966-9136, e-mail pam_layh@unc.edu; or the

World-Wide Web (includes state immunization contact information) at www.sph.

unc.edu/cdlhc.

1128 MMWR January 3, 1997
Notice to Readers

Availability of Surveillance Report

on Work-Related Lung Diseases

CDC’s National Institute for Occupational Safety and Health (NIOSH) has released

the Work-Related Lung Disease (WoRLD) Surveillance Report, 1996. This report, the

fourth in the series, summarizes occupational respiratory disease surveillance data,

focusing on pneumoconiosis (asbestosis, coal workers’ pneumoconiosis, silicosis,

byssinosis, unspecified/other pneumoconioses) mortality surveillance. The report is

organized into two sections—United States and States. The U.S. section updates

pneumoconiosis mortality surveillance data presented in the 1994 WoRLD report, by

incorporating new data for 1991 and 1992, and includes exposure data for asbestos,

silica, coal mine dust and a combined pneumoconiotic agent category. The States

section provides state-by-state profiles of pneumoconiosis mortality surveillance data

and is intended to provide a snapshot of each state’s pneumoconiosis mortality from

1968 to 1992.

Copies of the 1996 WoRLD report are available from Surveillance Section,

Epidemiological Investigations Branch, Division of Respiratory Disease Studies,

NIOSH, CDC, 1095 Willowdale Road, Morgantown, WV 26505-2888; fax (304) 285-

6111; e-mail world@niords1.em.cdc.gov.

Erratum: Vol. 45, No. 51

In the article “Estimates of Retailers Willing to Sell Tobacco to Minors—California,

August–September 1995 and June–July 1996,” there was an error in table 1 on page

1098. In the total line, the percentage point change should have been –7.7%.

Vol. 45 / Nos. 51 & 52 MMWR 1129
1130 MMWR January 3, 1997
FIGURE I. Selected notifiable disease reports, comparison of provisional 4-week totals

ending December 21, 1996, with historical data — United States

Anthrax - Plague 5

Brucellosis 94 Poliomyelitis, paralytic¶ -

Cholera 4 Psittacosis 45

Congenital rubella syndrome 2 Rabies, human 2

Cryptosporidiosis* 2,361 Rocky Mountain spotted fever (RMSF) 741

Diphtheria 1 Streptococcal toxic-shock syndrome* 15

Encephalitis: California* 110 Syphilis, congenital** 225

eastern equine* 2 Tetanus 27

St. Louis* 1 Toxic-shock syndrome 133

western equine* - Trichinosis 17

Hansen Disease 112 Typhoid fever 352

Hantavirus pulmonary syndrome*† 20 Yellow fever†† 1

HIV infection, pediatric*§ 242

Cum. 1996 Cum. 1996

TABLE I. Summary — provisional cases of selected notifiable diseases,

United States, cumulative, week ending December 21, 1996 (51st Week)

 -: no reported cases

 *Not notifiable in all states.

† Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases (NCID). § Updated monthly to the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention (NCHSTP), last

update November 26, 1996. ¶ Three suspected cases of polio with onset in 1996 has been reported to date.

**Updated quarterly from reports to the Division of STD Prevention, NCHSTP. ††This fatal case of yellow fever is the first occurrence of this disease reported in the United States since 1924. The infection

is presumed to have been acquired in Brazil.

DISEASE DECREASE INCREASE CASES CURRENT

4 WEEKS

Ratio (Log Scale)*

AAAA AAAA AAAA

AAAA

AA Beyond Historical Limits

0.0625 0.125 0.25 0.5 1 2 4

1,922

615

220

98

78

4

216

43

810

378

9

Hepatitis A

Hepatitis B

Hepatitis, C/Non-A, Non-B

Legionellosis

Malaria

Measles, Total

Mumps

Pertussis

Rabies, Animal

Rubella

AAAA AAAA AAAA AAAA

AAAA

AAAA

AAAA AAAA AAAA AAAA

AA

AA

AA

AA

AA

Meningococcal Infections

*Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and

subsequent 4-week periods for the past 5 years). The point where the hatched area begins is

based on the mean and two standard deviations of these 4-week totals.

Vol. 45 / Nos. 51 & 52 MMWR 1131
TABLE II. Provisional cases of selected notifiable diseases, United States,

weeks ending December 21, 1996, and December 23, 1995 (51st Week)

UNITED STATES 62,258 68,191 382,388 2,705 1,657 298,462 380,924 3,252 3,992 1,058 1,113

NEW ENGLAND 2,551 3,138 16,109 339 203 6,844 7,442 115 125 80 38

Maine 42 82 897 22 - 56 93 - - 5 6

N.H. 85 108 397 40 40 80 111 8 14 5 2

Vt. 19 28 U 35 33 47 69 39 14 5 1

Mass. 1,249 1,337 6,832 156 130 2,184 2,658 62 90 34 22

R.I. 167 211 1,793 16 - 480 537 6 7 31 7

Conn. 989 1,372 6,190 70 - 3,997 3,974 - - N N

MID. ATLANTIC 17,328 18,869 44,124 223 44 36,385 43,167 307 493 238 201

Upstate N.Y. 2,385 2,254 N 148 17 6,559 8,954 238 268 77 56

N.Y. City 9,497 10,021 18,756 17 - 10,373 16,206 1 1 16 6

N.J. 3,353 4,311 8,156 58 5 7,484 5,594 - 185 15 33

Pa. 2,093 2,283 17,212 N 22 11,969 12,413 68 39 130 106

E.N. CENTRAL 4,733 5,045 78,530 575 432 54,836 75,747 447 351 299 337

Ohio 1,058 1,034 16,894 171 106 12,180 22,988 33 15 113 150

Ind. 548 494 10,216 89 55 6,572 8,677 9 14 46 80

Ill. 2,084 2,048 22,469 217 133 16,531 20,241 72 82 9 36

Mich. 788 1,131 19,995 98 73 15,128 17,521 333 240 107 35

Wis. 255 338 8,956 N 65 4,425 6,320 - - 24 36

W.N. CENTRAL 1,443 1,547 27,310 600 362 12,202 19,443 149 89 65 75

Minn. 270 345 2,702 275 228 U 2,852 5 4 10 6

Iowa 82 104 4,165 125 101 1,144 1,477 77 14 11 21

Mo. 749 711 11,536 72 - 8,045 11,216 40 23 19 17

N. Dak. 11 5 922 17 17 33 35 - 6 - 3

S. Dak. 12 17 1,501 26 - 174 226 - 1 3 3

Nebr. 94 101 2,169 54 4 816 1,009 8 23 17 17

Kans. 225 264 4,315 31 12 1,990 2,628 19 18 5 8

S. ATLANTIC 15,559 17,213 53,234 141 73 93,657 106,461 247 241 172 166

Del. 264 302 1,148 2 2 1,419 2,189 1 - 11 2

Md. 2,164 2,559 6,730 N 8 14,334 13,627 5 7 34 27

D.C. 1,196 980 N - - 4,238 4,548 - - 8 5

Va. 1,097 1,489 11,285 N 35 8,878 10,344 16 21 37 23

W. Va. 112 124 1 N 3 559 630 9 44 2 4

N.C. 830 963 - 45 17 18,085 23,357 46 63 12 33

S.C. 808 870 - 13 8 10,984 12,105 34 19 8 30

Ga. 2,293 2,173 11,642 32 - 17,650 19,414 U 15 3 14

Fla. 6,795 7,753 22,428 37 - 17,510 20,247 136 72 57 28

E.S. CENTRAL 2,089 2,107 30,613 77 63 33,706 39,877 559 960 53 55

Ky. 362 269 6,466 14 10 4,083 4,707 28 34 9 10

Tenn. 743 855 12,920 36 50 11,578 13,590 388 924 23 25

Ala. 569 560 8,280 15 3 13,143 16,144 9 2 4 8

Miss. 415 423 U 12 - 4,902 5,436 134 U 17 12

W.S. CENTRAL 6,313 5,994 48,691 81 14 34,537 52,157 467 380 35 22

Ark. 247 275 1,643 13 5 3,763 5,675 18 7 1 6

La. 1,375 998 7,276 7 4 8,062 10,436 222 211 2 3

Okla. 245 257 7,154 13 1 4,731 5,625 69 52 5 5

Tex. 4,446 4,464 32,618 48 4 17,981 30,421 158 110 27 8

MOUNTAIN 1,801 2,107 17,072 226 106 6,741 9,201 544 475 57 115

Mont. 34 22 - 27 - 34 68 19 17 1 4

Idaho 37 43 1,494 39 13 98 139 96 58 - 3

Wyo. 6 18 577 11 9 35 50 181 189 7 12

Colo. 463 629 U 85 43 1,077 2,735 63 66 10 41

N. Mex. 153 155 3,862 13 2 920 1,036 69 52 2 6

Ariz. 535 632 7,255 N 27 3,432 3,660 74 56 22 13

Utah 178 149 1,544 34 - 278 279 21 13 8 16

Nev. 395 459 2,340 17 12 867 1,234 21 24 7 20

PACIFIC 10,440 12,171 66,705 443 360 19,554 27,429 417 878 59 104

Wash. 642 848 8,962 171 164 1,976 2,701 51 213 6 21

Oreg. 439 451 5,147 94 67 643 807 9 37 1 -

Calif. 9,160 10,558 49,559 172 117 16,031 22,712 144 505 43 78

Alaska 30 63 1,286 6 3 440 652 3 3 1 -

Hawaii 169 251 1,751 N 9 464 557 210 120 8 5

Guam 4 - 177 N - 32 95 1 6 2 1

P.R. 2,170 2,395 N 20 U 377 587 77 207 - -

V.I. 18 31 N N U - - - - - -

Amer. Samoa - - - N U - 41 - - - -

C.N.M.I. 1 - N N U 11 51 - 5 - -

N: Not notifiable U: Unavailable -: no reported cases C.N.M.I.: Commonwealth of Northern Mariana Islands

*Updated monthly to the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, last update

November 26, 1996.

†National Electronic Telecommunications System for Surveillance.

§Public Health Laboratory Information System. 

Reporting Area

AIDS* Chlamydia

Escherichia

coli O157:H7

Gonorrhea

Hepatitis

NETSS C/NA,NB Legionellosis † PHLIS§

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1996

Cum.

1996

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

1132 MMWR January 3, 1997
TABLE II. (Cont’d.) Provisional cases of selected notifiable diseases, United States,

weeks ending December 21, 1996, and December 23, 1995 (51st Week)

UNITED STATES 13,659 10,986 1,520 1,292 3,122 2,932 10,764 15,999 18,705 20,789 6,600 7,407

NEW ENGLAND 3,917 2,032 73 49 155 148 186 347 422 514 721 1,437

Maine 54 32 10 7 17 15 - 2 16 23 121 46

N.H. 48 27 3 2 10 24 1 1 16 20 53 147

Vt. 15 9 8 1 4 11 - - 1 4 133 174

Mass. 340 148 24 19 63 48 85 69 225 284 112 398

R.I. 523 336 10 4 16 6 4 4 32 48 37 317

Conn. 2,937 1,480 18 16 45 44 96 271 132 135 265 355

MID. ATLANTIC 8,408 7,274 395 375 299 350 454 846 3,550 4,180 1,434 1,904

Upstate N.Y. 4,491 3,707 84 67 85 99 72 80 435 512 1,063 1,150

N.Y. City 390 441 213 206 40 52 120 359 1,846 2,288 - -

N.J. 1,906 1,644 67 72 79 73 144 173 735 778 138 325

Pa. 1,621 1,482 31 30 95 126 118 234 534 602 233 429

E.N. CENTRAL 83 441 152 160 426 402 1,461 2,758 1,945 1,980 91 101

Ohio 51 30 14 13 156 113 527 896 303 270 13 12

Ind. 29 19 14 20 61 60 206 331 184 173 8 14

Ill. 3 18 70 78 121 105 388 1,044 978 1,013 25 16

Mich. - 5 39 26 46 72 176 292 373 424 31 41

Wis. U 369 15 23 42 52 164 195 107 100 14 18

W.N. CENTRAL 224 232 48 31 253 187 333 704 481 578 513 376

Minn. 126 134 21 10 35 26 51 45 112 140 29 30

Iowa 20 16 4 3 56 30 21 45 68 66 236 137

Mo. 37 53 10 8 98 70 213 576 199 231 20 30

N. Dak. 1 - 1 2 5 2 - - 6 5 71 28

S. Dak. - - - 2 10 10 - - 17 26 119 103

Nebr. 5 6 3 3 25 21 12 12 21 21 5 5

Kans. 35 23 9 3 24 28 36 26 58 89 33 43

S. ATLANTIC 717 697 308 249 616 498 3,728 4,035 3,431 3,700 2,737 2,163

Del. 105 53 4 1 2 6 35 19 30 56 76 92

Md. 428 443 85 63 70 42 655 520 291 395 618 434

D.C. 3 3 7 16 10 8 130 100 130 98 11 11

Va. 51 54 57 54 61 62 377 600 293 283 586 448

W. Va. 11 24 6 4 15 10 3 10 53 70 97 116

N.C. 65 83 30 18 77 83 1,114 1,118 551 517 696 463

S.C. 9 17 12 3 65 56 384 571 320 309 87 121

Ga. 1 14 27 37 138 109 669 721 603 683 298 273

Fla. 44 6 80 53 178 122 361 376 1,160 1,289 268 205

E.S. CENTRAL 74 72 37 27 230 215 2,288 3,326 1,221 1,435 217 283

Ky. 25 15 7 3 29 50 151 185 227 313 41 28

Tenn. 21 28 14 10 60 82 837 910 349 440 88 98

Ala. 7 12 8 11 89 45 528 656 420 414 84 148

Miss. 21 17 8 3 52 38 772 1,575 225 268 4 9

W.S. CENTRAL 121 115 64 49 333 359 1,653 3,195 2,410 3,078 401 562

Ark. 23 9 - 2 34 36 234 474 197 229 27 50

La. 8 9 7 6 58 61 493 994 235 399 17 42

Okla. 25 45 - 1 43 45 175 192 173 346 35 29

Tex. 65 52 57 40 198 217 751 1,535 1,805 2,104 322 441

MOUNTAIN 7 12 62 63 171 206 144 193 621 670 153 175

Mont. - - 7 3 6 4 - 4 14 10 24 44

Idaho 1 - - 1 25 14 4 - 10 14 - 3

Wyo. 2 3 7 - 3 8 2 1 6 5 33 27

Colo. - - 26 26 41 48 23 99 78 92 42 9

N. Mex. 1 1 4 7 27 35 1 9 83 83 6 6

Ariz. - 1 7 14 40 60 93 45 251 318 36 56

Utah 1 1 5 6 17 18 3 4 51 38 5 15

Nev. 2 6 6 6 12 19 18 31 128 110 7 15

PACIFIC 108 111 381 289 639 567 517 595 4,624 4,654 333 406

Wash. 18 10 21 21 101 97 6 15 231 271 6 15

Oreg. 19 19 23 19 119 106 12 22 168 149 5 4

Calif. 70 82 324 232 403 345 495 556 3,965 3,976 313 380

Alaska - - 3 5 10 15 - 2 70 73 9 7

Hawaii 1 - 10 12 6 4 4 - 190 185 - -

Guam - - - 2 1 3 3 8 35 112 - -

P.R. - - 2 1 5 24 119 284 84 162 43 39

V.I. - - - 2 - - - - - - - -

Amer. Samoa - - - - - - - - - 5 - -

C.N.M.I. - - - 1 - - 1 9 - 41 - -

N: Not notifiable U: Unavailable -: no reported cases

Reporting Area

Lyme

Disease Malaria

Meningococcal

Disease

Syphilis

(Primary & Secondary) Tuberculosis Rabies, Animal

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Vol. 45 / Nos. 51 & 52 MMWR 1133
TABLE III. Provisional cases of selected notifiable diseases preventable by vaccination,

United States, weeks ending December 21, 1996,

and December 23, 1995 (51st Week)

UNITED STATES 1,031 1,102 28,507 29,724 9,870 9,846 1 438 - 50

NEW ENGLAND 70 39 421 311 205 232 - 14 - 1

Maine - 3 25 30 2 12 - - - -

N.H. 10 10 25 12 20 22 - - - -

Vt. 2 2 11 6 11 7 - 1 - 1

Mass. 56 13 200 142 75 96 - 12 - -

R.I. 2 5 25 35 12 9 - - - -

Conn. - 6 135 86 85 86 - 1 - -

MID. ATLANTIC 145 169 1,837 1,926 1,398 1,477 - 23 - 5

Upstate N.Y. 12 41 426 489 330 383 - - - -

N.Y. City 40 34 599 910 563 458 - 9 - 3

N.J. 64 31 344 300 247 362 - 3 - -

Pa. 29 63 468 227 258 274 - 11 - 2

E.N. CENTRAL 169 185 2,398 3,133 996 1,106 - 6 - 8

Ohio 94 99 765 1,756 119 111 - 2 - 4

Ind. 14 20 357 186 130 239 - - - -

Ill. 39 46 612 647 264 280 - 2 - 1

Mich. 11 18 495 361 416 396 - - - 3

Wis. 11 2 169 183 67 80 - 2 - -

W.N. CENTRAL 55 80 2,593 1,892 563 618 - 20 - 3

Minn. 35 43 147 180 71 63 - 16 - 2

Iowa 7 3 342 101 93 46 - - - 1

Mo. 10 27 1,353 1,288 313 418 - 3 - -

N. Dak. - - 137 23 2 5 - - - -

S. Dak. 1 1 42 84 5 2 - - - -

Nebr. 1 3 218 57 48 33 - - - -

Kans. 1 3 354 159 31 51 U 1 U -

S. ATLANTIC 195 211 1,503 1,142 1,529 1,276 - 5 - 9

Del. 7 - 21 10 9 9 - 1 - -

Md. 63 68 251 217 292 254 - - - 2

D.C. 6 - 36 25 31 21 - 1 - -

Va. 10 28 184 222 136 113 U - U 3

W. Va. 10 9 18 24 32 53 U - U -

N.C. 25 31 176 107 327 286 - 3 - 1

S.C. 5 3 57 44 101 49 - - - -

Ga. 40 65 154 61 32 73 - - - 2

Fla. 29 7 606 432 569 418 - - - 1

E.S. CENTRAL 27 11 1,202 2,179 847 811 - 2 - -

Ky. 4 5 46 44 64 66 - - - -

Tenn. 13 - 744 1,829 488 636 - 2 - -

Ala. 9 5 204 89 73 109 - - - -

Miss. 1 1 208 217 222 U U - U -

W.S. CENTRAL 41 71 6,047 4,615 1,293 1,418 - 26 - 2

Ark. - 6 495 616 77 75 - - - -

La. 5 1 205 190 150 238 - - - -

Okla. 31 31 2,430 1,360 59 163 - - - -

Tex. 5 33 2,917 2,449 1,007 942 - 26 - 2

MOUNTAIN 62 119 4,454 4,235 1,138 851 - 154 - 5

Mont. - 1 113 168 16 23 - - - -

Idaho 1 6 241 347 86 97 - 2 - -

Wyo. - 9 40 103 44 27 - 1 - -

Colo. 15 16 518 497 135 135 - 4 - 3

N. Mex. 11 16 350 801 409 316 - 17 - -

Ariz. 17 30 1,707 1,317 232 119 - 8 - -

Utah 9 11 1,071 680 124 71 - 117 - 2

Nev. 9 30 414 322 92 63 - 5 - -

PACIFIC 267 217 8,052 10,291 1,901 2,057 1 188 - 17

Wash. 4 9 744 832 114 192 - 51 - -

Oreg. 32 27 835 2,674 118 116 - 10 - 1

Calif. 225 175 6,325 6,572 1,639 1,704 - 37 - 9

Alaska 3 2 44 48 18 13 - 63 - -

Hawaii 3 4 104 165 12 32 1 27 - 7

Guam - - 5 8 - 5 U - U -

P.R. 1 3 141 107 372 626 - 8 - -

V.I. - - - 9 - 16 U - U -

Amer. Samoa - - - 6 - - U - U -

C.N.M.I. 10 11 1 24 5 22 U - U -

N: Not notifiable U: Unavailable -: no reported cases

*Of 270 cases among children aged <5 years, serotype was reported for 94 and of those, 30 were type b. †For imported measles, cases include only those resulting from importation from other countries.

Reporting Area

H. influenzae,

invasive

Hepatitis (viral), by type Measles (Rubeola)

A B Indigenous Imported†

Cum.

1996*

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995 1996

Cum.

1996 1996

Cum.

1996

1134 MMWR January 3, 1997
UNITED STATES 488 297 14 641 863 178 6,262 4,478 1 210 122

NEW ENGLAND 15 12 1 3 12 40 1,489 676 - 26 50

Maine - - - - 4 - 24 47 - - -

N.H. - - - - 1 8 165 55 - - 1

Vt. 2 - - - - 11 231 80 - 2 -

Mass. 12 5 - 2 3 20 1,001 458 - 20 10

R.I. - 5 1 1 1 - 32 4 - - -

Conn. 1 2 - - 3 1 36 32 - 4 39

MID. ATLANTIC 28 13 2 89 126 47 731 417 - 13 15

Upstate N.Y. - 1 1 27 31 43 480 225 - 5 4

N.Y. City 12 5 - 17 16 - 48 56 - 5 8

N.J. 3 7 - 3 21 - 19 19 - 2 3

Pa. 13 - 1 42 58 4 184 117 - 1 -

E.N. CENTRAL 14 15 6 104 170 14 597 593 - 3 4

Ohio 6 2 6 49 53 7 280 175 - - -

Ind. - - - 8 9 1 94 59 - - -

Ill. 3 2 - 20 48 6 166 133 - 1 -

Mich. 3 5 - 26 60 - 52 99 - 2 4

Wis. 2 6 - 1 - - 5 127 - - -

W.N. CENTRAL 23 3 - 19 47 36 456 253 - - 1

Minn. 18 - - 6 8 20 353 125 - - -

Iowa 1 - - 3 11 3 25 11 - - -

Mo. 3 2 - 7 23 7 54 61 - - -

N. Dak. - - - 2 1 - 1 8 - - -

S. Dak. - - - - - - 4 12 - - -

Nebr. - - - - 4 6 15 14 - - -

Kans. 1 1 U 1 - U 4 22 U - 1

S. ATLANTIC 14 19 1 109 150 6 695 342 - 100 13

Del. 1 - - - - - 27 10 - - -

Md. 2 1 1 31 37 3 260 49 - - 1

D.C. 1 - - 1 - 1 5 6 - 2 -

Va. 3 - U 16 25 U 99 31 U 2 -

W. Va. - - U - - U 6 - U - -

N.C. 4 - - 21 41 - 131 110 - 85 1

S.C. - - - 7 11 1 49 27 - 1 -

Ga. 2 4 - 3 10 - 18 25 - - -

Fla. 1 14 - 30 26 1 100 84 - 10 11

E.S. CENTRAL 2 - - 23 19 1 197 276 - 2 1

Ky. - - - - - - 140 26 - - -

Tenn. 2 - - 3 5 - 21 209 - - 1

Ala. - - - 5 4 1 27 38 - 2 -

Miss. - - U 15 10 U 9 3 N N N

W.S. CENTRAL 28 34 2 46 56 2 127 294 - 3 7

Ark. - 2 - 1 7 - 10 39 - - -

La. - 18 - 18 15 - 11 21 - 1 -

Okla. - - - 1 1 - 19 31 - - -

Tex. 28 14 2 26 33 2 87 203 - 2 7

MOUNTAIN 159 70 - 22 31 16 462 681 - 7 4

Mont. - - - - 1 - 36 9 - - -

Idaho 2 2 - - 4 2 110 107 - 2 -

Wyo. 1 - - 1 - - 8 1 - - -

Colo. 7 26 - 3 2 13 152 114 - 3 -

N. Mex. 17 31 N N N 1 62 147 - - -

Ariz. 8 10 - 1 2 - 29 155 - 1 3

Utah 119 - - 2 11 - 24 31 - - 1

Nev. 5 1 - 15 11 - 41 117 - 1 -

PACIFIC 205 131 2 226 252 16 1,508 946 1 56 27

Wash. 51 20 1 21 15 3 722 355 - 2 1

Oreg. 11 1 - - - - 35 66 - 1 -

Calif. 46 108 1 173 211 13 718 464 1 50 21

Alaska 63 - - 3 12 - 4 1 - - -

Hawaii 34 2 - 29 14 - 29 60 - 3 5

Guam - - U 5 4 U 1 2 U - 1

P.R. 8 3 - 1 3 - 1 2 - - -

V.I. - - U - 3 U - - U - -

Amer. Samoa - - U - - U - - U - -

C.N.M.I. - - U - 1 U - - U - -

N: Not notifiable U: Unavailable -: no reported cases

TABLE III. (Cont’d.) Provisional cases of selected notifiable diseases preventable

by vaccination, United States, weeks ending December 21, 1996,

and December 23, 1995 (51st Week)

Reporting Area

Measles (Rubeola), cont’d.

Total Mumps Pertussis Rubella

Cum.

1996

Cum.

1995 1996

Cum.

1996

Cum.

1995 1996

Cum.

1996

Cum.

1995 1996

Cum.

1996

Cum.

1995

Vol. 45 / Nos. 51 & 52 MMWR 1135
NEW ENGLAND 720 550 107 37 14 12 71

Boston, Mass. 164 111 40 6 4 3 8

Bridgeport, Conn. 51 40 7 2 1 1 3

Cambridge, Mass. 15 12 1 2 - - 2

Fall River, Mass. 32 27 3 1 1 - -

Hartford, Conn. 70 52 8 6 3 1 2

Lowell, Mass. 38 27 8 2 - 1 4

Lynn, Mass. 14 12 1 1 - - 3

New Bedford, Mass. 32 28 1 3 - - 1

New Haven, Conn. 48 36 6 3 3 - 9

Providence, R.I. 80 67 10 1 - 2 12

Somerville, Mass. 11 9 1 - 1 - 3

Springfield, Mass. 55 39 9 6 - 1 10

Waterbury, Conn. 29 22 3 2 1 1 3

Worcester, Mass. 81 68 9 2 - 2 11

MID. ATLANTIC 2,764 1,931 513 230 52 37 184

Albany, N.Y. 51 39 7 2 1 2 2

Allentown, Pa. 25 20 4 - 1 - -

Buffalo, N.Y. 106 81 13 10 1 1 8

Camden, N.J. 33 20 4 4 3 2 4

Elizabeth, N.J. 23 13 5 4 1 - 1

Erie, Pa.§ 52 43 7 2 - - 4

Jersey City, N.J. 40 20 9 7 2 2 -

New York City, N.Y. 1,587 1,085 324 131 27 20 90

Newark, N.J. 61 26 17 13 3 2 7

Paterson, N.J. 26 20 5 1 - - 2

Philadelphia, Pa. 300 192 50 42 10 5 15

Pittsburgh, Pa.§ 87 63 19 4 - 1 9

Reading, Pa. 16 15 1 - - - 9

Rochester, N.Y. 116 94 14 6 1 1 14

Schenectady, N.Y. 26 19 7 - - - 2

Scranton, Pa.§ 39 33 5 1 - - 2

Syracuse, N.Y. 97 84 8 2 2 1 9

Trenton, N.J. 33 25 7 1 - - 5

Utica, N.Y. 17 15 2 - - - -

Yonkers, N.Y. 29 24 5 - - - 1

E.N. CENTRAL 2,148 1,482 433 126 60 47 146

Akron, Ohio 61 51 5 3 - 2 -

Canton, Ohio 47 39 6 2 - - 5

Chicago, Ill. 382 224 93 35 19 11 30

Cincinnati, Ohio 83 58 17 5 1 2 9

Cleveland, Ohio 147 95 29 13 4 6 4

Columbus, Ohio 211 152 43 7 5 4 12

Dayton, Ohio 133 102 25 3 2 1 7

Detroit, Mich. 232 136 63 21 6 6 8

Evansville, Ind. 68 54 10 1 1 2 3

Fort Wayne, Ind. 61 47 13 - 1 - 5

Gary, Ind. U U U U U U U

Grand Rapids, Mich. 76 56 9 6 1 4 10

Indianapolis, Ind. 217 150 41 13 11 2 10

Madison, Wis. 57 43 10 3 1 - 9

Milwaukee, Wis. 56 43 9 2 2 - 16

Peoria, Ill. 53 36 12 1 3 1 2

Rockford, Ill. 52 42 8 - 2 - 4

South Bend, Ind. 54 40 8 2 - 4 4

Toledo, Ohio 100 75 20 3 - 2 4

Youngstown, Ohio 58 39 12 6 1 - 4

W.N. CENTRAL 961 694 156 60 20 25 55

Des Moines, Iowa 67 50 12 4 1 - 8

Duluth, Minn. 27 23 3 - - 1 1

Kansas City, Kans. 42 31 5 4 2 - -

Kansas City, Mo. 118 87 15 8 2 - 6

Lincoln, Nebr. 37 28 7 1 - 1 2

Minneapolis, Minn. 257 186 45 16 3 7 21

Omaha, Nebr. 101 69 17 10 1 4 7

St. Louis, Mo. 152 108 26 6 5 7 2

St. Paul, Minn. 69 51 11 5 1 1 2

Wichita, Kans. 91 61 15 6 5 4 6

S. ATLANTIC 1,455 926 284 148 54 42 67

Atlanta, Ga. 221 123 52 34 9 3 4

Baltimore, Md. 213 132 44 28 4 5 15

Charlotte, N.C. 100 55 27 13 4 1 3

Jacksonville, Fla. 168 120 28 13 2 4 3

Miami, Fla. 111 77 15 10 4 5 1

Norfolk, Va. 73 53 10 5 3 2 5

Richmond, Va. 94 59 21 9 - 5 10

Savannah, Ga. 49 36 8 3 - 2 4

St. Petersburg, Fla. 47 35 9 2 - 1 1

Tampa, Fla. 185 130 27 13 12 3 18

Washington, D.C. 169 86 40 16 16 11 3

Wilmington, Del. 25 20 3 2 - - -

E.S. CENTRAL 698 474 142 53 18 9 41

Birmingham, Ala. 136 85 36 11 - 2 5

Chattanooga, Tenn. 108 83 19 5 - 1 15

Knoxville, Tenn. 71 55 9 4 3 - 7

Lexington, Ky. 22 15 6 - 1 - -

Memphis, Tenn. 126 84 26 11 3 2 4

Mobile, Ala. 59 43 9 4 3 - -

Montgomery, Ala. 46 29 9 4 2 2 3

Nashville, Tenn. 130 80 28 14 6 2 7

W.S. CENTRAL 1,386 919 254 150 34 29 89

Austin, Tex. 78 50 12 14 2 - 3

Baton Rouge, La. 45 32 7 3 1 2 1

Corpus Christi, Tex. 60 41 12 4 1 2 4

Dallas, Tex. 203 133 39 26 5 - 4

El Paso, Tex. 101 74 10 13 3 1 8

Ft. Worth, Tex. 65 38 17 4 3 3 2

Houston, Tex. 374 235 75 46 11 7 32

Little Rock, Ark. 55 35 9 5 1 5 7

New Orleans, La. U U U U U U U

San Antonio, Tex. 199 141 33 18 4 3 11

Shreveport, La. 74 54 12 5 2 1 10

Tulsa, Okla. 132 86 28 12 1 5 7

MOUNTAIN 1,060 741 199 77 28 15 99

Albuquerque, N.M. 119 80 24 10 1 4 5

Colo. Springs, Colo. 72 48 12 6 4 2 8

Denver, Colo. 154 118 22 12 1 1 22

Las Vegas, Nev. 215 144 43 15 8 5 13

Ogden, Utah 20 13 5 1 1 - 4

Phoenix, Ariz. 199 126 49 18 5 1 15

Pueblo, Colo. 23 18 4 1 - - 2

Salt Lake City, Utah 113 75 20 9 7 2 13

Tucson, Ariz. 145 119 20 5 1 - 17

PACIFIC 1,548 1,085 264 125 33 39 139

Berkeley, Calif. 17 15 2 - - - 2

Fresno, Calif. 106 61 21 13 4 7 6

Glendale, Calif. 17 14 2 1 - - 3

Honolulu, Hawaii 86 64 15 3 1 3 8

Long Beach, Calif. 74 56 14 2 2 - 13

Los Angeles, Calif. 250 174 43 19 7 7 13

Pasadena, Calif. 27 22 3 1 1 - 5

Portland, Oreg. 145 116 18 8 1 2 14

Sacramento, Calif. U U U U U U U

San Diego, Calif. 152 92 34 13 5 6 11

San Francisco, Calif. 157 114 28 11 1 3 21

San Jose, Calif. 151 101 31 13 1 5 16

Santa Cruz, Calif. 38 31 2 5 - - 4

Seattle, Wash. 168 117 22 17 8 4 14

Spokane, Wash. 59 42 12 4 - 1 5

Tacoma, Wash. 101 66 17 15 2 1 4

TOTAL 12,740¶ 8,802 2,352 1,006 313 255 891

Reporting Area >65 45-64 25-44 1-24 <1

P&I†

All Total

Ages

All Causes, By Age (Years)

Reporting Area

P&I†

All Total

Ages

All Causes, By Age (Years)

>65 45-64 25-44 1-24 <1

U: Unavailable -: no reported cases

*Mortality data in this table are voluntarily reported from 121 cities in the United States, most of which have populations of 100,000 or

more. A death is reported by the place of its occurrence and by the week that the death certificate was filed. Fetal deaths are not

included.

†Pneumonia and influenza.

§Because of changes in reporting methods in these 3 Pennsylvania cities, these numbers are partial counts for the current week. Complete

counts will be available in 4 to 6 weeks.

¶Total includes unknown ages.

TABLE IV. Deaths in 121 U.S. cities,* week ending

December 21, 1996 (51st Week)

1136 MMWR January 3, 1997
FIGURE I. Selected notifiable disease reports, comparison of provisional 4-week totals

ending December 28, 1996, with historical data — United States

Anthrax - Plague 5

Brucellosis 94 Poliomyelitis, paralytic¶ -

Cholera 4 Psittacosis 45

Congenital rubella syndrome 2 Rabies, human 2

Cryptosporidiosis* 2,393 Rocky Mountain spotted fever (RMSF) 745

Diphtheria 1 Streptococcal toxic-shock syndrome* 16

Encephalitis: California* 111 Syphilis, congenital** 225

eastern equine* 2 Tetanus 27

St. Louis* 1 Toxic-shock syndrome 136

western equine* - Trichinosis 17

Hansen Disease 113 Typhoid fever 355

Hantavirus pulmonary syndrome*† 20 Yellow fever†† 1

HIV infection, pediatric*§ 257

Cum. 1996 Cum. 1996

TABLE I. Summary — provisional cases of selected notifiable diseases,

United States, cumulative, week ending December 28, 1996 (52nd Week)

 -: no reported cases

 *Not notifiable in all states.

† Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases (NCID). § Updated monthly to the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention (NCHSTP), last

update December 17, 1996. ¶ Three suspected cases of polio with onset in 1996 has been reported to date.

**Updated quarterly from reports to the Division of STD Prevention, NCHSTP. ††This fatal case of yellow fever is the first occurrence of this disease reported in the United States since 1924. The infection

is presumed to have been acquired in Brazil.

DISEASE DECREASE INCREASE CASES CURRENT

4 WEEKS

Ratio (Log Scale)*

AAAA AAAA

AAAA

AA

AA

AA Beyond Historical Limits

0.0625 0.125 0.25 0.5 1 2 4

2,017

622

250

95

80

5

210

44

810

366

9

Hepatitis A

Hepatitis B

Hepatitis, C/Non-A, Non-B

Legionellosis

Malaria

Measles, Total

Meningococcal Infections

Mumps

Pertussis

Rabies, Animal

Rubella

AAAA AAAA AAAA AAAAAAAA

AAAA

AAAA

AAAA

*Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and

subsequent 4-week periods for the past 5 years). The point where the hatched area begins is

based on the mean and two standard deviations of these 4-week totals.

Vol. 45 / Nos. 51 & 52 MMWR 1137
TABLE II. Provisional cases of selected notifiable diseases, United States,

weeks ending December 28, 1996, and December 30, 1995 (52nd Week)

UNITED STATES 65,475 71,210 390,896 2,726 1,657 308,737 393,168 3,321 4,576 1,079 1,241

NEW ENGLAND 2,752 3,598 16,209 340 203 6,870 7,533 115 142 80 41

Maine 49 130 916 22 - 57 95 - - 5 6

N.H. 93 110 397 40 40 80 111 8 14 5 2

Vt. 19 42 U 36 33 47 69 39 14 5 2

Mass. 1,307 1,440 6,874 156 130 2,203 2,658 62 106 34 24

R.I. 172 222 1,832 16 - 486 545 6 8 31 7

Conn. 1,112 1,654 6,190 70 - 3,997 4,055 - - N N

MID. ATLANTIC 18,077 19,162 44,190 225 44 36,583 44,283 310 590 238 226

Upstate N.Y. 2,421 2,355 N 149 17 6,748 9,583 240 341 77 65

N.Y. City 9,952 10,032 18,756 17 - 10,373 16,282 1 1 16 6

N.J. 3,542 4,407 8,222 59 5 7,493 5,741 - 189 15 33

Pa. 2,162 2,368 17,212 N 22 11,969 12,677 69 59 130 122

E.N. CENTRAL 5,058 5,389 79,066 578 432 54,995 77,342 454 358 308 341

Ohio 1,123 1,104 17,030 172 106 12,180 23,176 35 15 116 151

Ind. 596 523 10,216 89 55 6,572 9,134 9 14 46 81

Ill. 2,198 2,218 22,580 218 133 16,548 20,515 75 86 9 36

Mich. 878 1,195 20,277 99 73 15,267 18,117 335 243 107 35

Wis. 263 349 8,963 N 65 4,428 6,400 - - 30 38

W.N. CENTRAL 1,548 1,710 27,515 602 362 12,299 20,187 156 91 66 121

Minn. 304 366 2,702 275 228 U 2,852 7 4 10 49

Iowa 92 116 4,165 126 101 1,144 1,723 81 15 11 21

Mo. 799 787 11,691 72 - 8,132 11,303 40 23 19 19

N. Dak. 12 5 925 17 17 33 35 - 7 - 3

S. Dak. 14 18 1,504 26 - 172 244 - 1 3 3

Nebr. 94 114 2,169 54 4 816 1,233 8 23 17 18

Kans. 233 304 4,359 32 12 2,002 2,797 20 18 6 8

S. ATLANTIC 16,240 17,942 54,111 144 73 95,044 112,972 251 316 177 199

Del. 285 316 1,148 2 2 1,419 2,201 1 - 11 2

Md. 2,239 2,567 6,889 N 8 14,835 13,931 5 7 34 29

D.C. 1,200 1,030 N - - 4,336 4,548 - - 10 5

Va. 1,146 1,607 11,652 N 35 9,203 10,344 16 21 39 28

W. Va. 121 125 1 N 3 559 652 9 44 2 4

N.C. 895 1,002 - 47 17 18,252 28,490 46 64 12 34

S.C. 848 977 - 13 8 10,984 12,105 34 21 8 30

Ga. 2,410 2,309 11,642 32 - 17,671 19,825 U 28 3 19

Fla. 7,096 8,009 22,779 38 - 17,785 20,876 140 131 58 48

E.S. CENTRAL 2,283 2,268 35,631 77 63 41,749 40,235 569 1,020 54 56

Ky. 401 297 6,597 14 10 4,162 4,760 28 34 9 10

Tenn. 826 894 12,920 36 50 11,578 13,894 388 983 23 26

Ala. 606 637 13,167 15 3 21,107 16,145 9 3 5 8

Miss. 450 440 U 12 - 4,902 5,436 144 U 17 12

W.S. CENTRAL 6,808 6,121 48,768 82 14 34,643 52,724 494 631 35 32

Ark. 269 277 1,663 13 5 3,813 5,743 18 8 1 8

La. 1,449 1,083 7,276 7 4 8,062 10,436 244 222 2 3

Okla. 262 295 7,211 14 1 4,787 5,652 69 54 5 8

Tex. 4,828 4,466 32,618 48 4 17,981 30,893 163 347 27 13

MOUNTAIN 2,002 2,260 17,308 229 106 6,824 9,509 554 519 58 116

Mont. 34 25 - 27 - 34 71 19 18 1 4

Idaho 39 48 1,505 40 13 98 140 98 58 - 3

Wyo. 7 18 592 11 9 36 50 186 223 7 12

Colo. 508 672 U 86 43 1,077 2,803 63 69 11 42

N. Mex. 204 164 3,862 14 2 920 1,067 69 53 2 6

Ariz. 593 675 7,354 N 27 3,480 3,841 77 59 22 13

Utah 190 164 1,555 34 - 279 280 21 13 8 16

Nev. 427 494 2,440 17 12 900 1,257 21 26 7 20

PACIFIC 10,706 12,760 68,098 449 360 19,730 28,383 418 909 63 109

Wash. 768 884 9,004 171 164 1,982 2,765 51 234 6 22

Oreg. 462 458 5,250 96 67 649 854 9 37 1 -

Calif. 9,250 11,090 50,738 176 117 16,176 23,539 144 511 47 82

Alaska 30 69 1,331 6 3 454 660 3 3 1 -

Hawaii 196 259 1,775 N 9 469 565 211 124 8 5

Guam 4 - 177 N - 32 96 1 6 2 1

P.R. 2,242 2,585 N 21 U 395 596 77 216 - -

V.I. 18 39 N N U - - - - - -

Amer. Samoa - - - N U - 41 - - - -

C.N.M.I. 1 - N N U 11 51 - 5 - -

N: Not notifiable U: Unavailable -: no reported cases C.N.M.I.: Commonwealth of Northern Mariana Islands

*Updated monthly to the Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, last update December 24, 1996. †National Electronic Telecommunications System for Surveillance.

§Public Health Laboratory Information System. 

Reporting Area

AIDS* Chlamydia

Escherichia

coli O157:H7

Gonorrhea

Hepatitis

NETSS C/NA,NB Legionellosis † PHLIS§

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1996

Cum.

1996

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

1138 MMWR January 3, 1997
TABLE II. (Cont’d.) Provisional cases of selected notifiable diseases, United States,

weeks ending December 28, 1996, and December 30, 1995 (52nd Week)

UNITED STATES 13,807 11,700 1,542 1,419 3,176 3,243 11,110 16,225 19,096 22,352 6,676 7,811

NEW ENGLAND 3,935 2,164 74 52 157 165 187 350 446 564 728 1,512

Maine 55 45 10 7 17 17 1 2 16 23 125 101

N.H. 48 28 4 2 11 29 1 1 21 23 53 152

Vt. 16 9 8 1 4 11 - - 4 4 134 179

Mass. 342 189 24 21 64 51 85 69 234 330 114 401

R.I. 537 345 10 4 16 7 4 4 39 49 37 317

Conn. 2,937 1,548 18 17 45 50 96 274 132 135 265 362

MID. ATLANTIC 8,505 7,703 404 402 303 372 454 874 3,614 4,545 1,447 1,923

Upstate N.Y. 4,578 3,983 89 75 86 106 72 85 445 621 1,075 1,157

N.Y. City 390 455 217 222 40 54 120 362 1,873 2,445 - -

N.J. 1,916 1,703 67 73 79 74 144 188 753 848 139 326

Pa. 1,621 1,562 31 32 98 138 118 239 543 631 233 440

E.N. CENTRAL 85 441 153 160 442 419 1,471 2,787 1,952 2,044 91 113

Ohio 53 30 15 13 159 115 530 896 303 280 13 12

Ind. 29 19 14 20 61 65 206 335 184 199 8 24

Ill. 3 18 70 78 126 110 388 1,057 990 1,024 25 16

Mich. - 5 39 26 50 75 183 303 373 424 31 43

Wis. U 369 15 23 46 54 164 196 102 117 14 18

W.N. CENTRAL 226 306 48 36 258 201 334 737 487 616 517 396

Minn. 126 208 21 12 35 31 51 45 112 156 29 37

Iowa 20 16 4 3 57 31 21 48 68 72 237 141

Mo. 37 53 10 9 99 76 214 584 198 244 20 30

N. Dak. 1 - 1 2 5 2 - - 6 5 71 32

S. Dak. - - - 2 10 11 - - 17 28 119 105

Nebr. 5 6 3 4 27 22 12 13 21 22 5 5

Kans. 37 23 9 4 25 28 36 47 65 89 36 46

S. ATLANTIC 739 726 311 277 623 601 3,728 4,072 3,462 4,111 2,780 2,254

Del. 105 56 4 1 2 6 35 19 30 56 76 96

Md. 445 454 85 63 71 42 675 533 298 408 637 439

D.C. 3 3 8 16 10 8 130 100 130 98 11 11

Va. 53 55 58 55 62 64 386 600 293 359 592 459

W. Va. 12 26 6 4 16 10 3 11 57 71 100 116

N.C. 66 84 30 20 79 86 1,070 1,132 558 519 696 466

S.C. 9 17 13 3 65 59 384 571 329 309 88 125

Ga. 1 14 27 41 139 124 679 723 607 743 303 294

Fla. 45 17 80 74 179 202 366 383 1,160 1,548 277 248

E.S. CENTRAL 76 73 37 27 237 244 2,617 3,331 1,257 1,485 224 285

Ky. 25 16 7 3 29 51 154 185 256 327 42 28

Tenn. 21 28 14 10 60 106 837 914 349 465 88 98

Ala. 9 12 8 11 94 49 854 657 425 423 90 150

Miss. 21 17 8 3 54 38 772 1,575 227 270 4 9

W.S. CENTRAL 121 160 64 100 338 404 1,655 3,248 2,485 3,441 401 728

Ark. 23 11 - 3 34 39 234 474 197 271 27 52

La. 8 9 7 7 58 63 493 1,019 235 454 17 54

Okla. 25 63 - 1 43 49 177 198 174 346 35 32

Tex. 65 77 57 89 203 253 751 1,557 1,879 2,370 322 590

MOUNTAIN 8 13 65 66 172 218 146 195 631 701 154 192

Mont. - - 7 3 6 4 - 4 14 21 24 46

Idaho 2 - - 2 25 21 4 - 12 14 - 3

Wyo. 2 4 7 1 3 8 2 1 6 5 33 32

Colo. - - 27 26 42 49 23 100 78 95 42 16

N. Mex. 1 1 4 7 27 36 1 9 83 84 6 6

Ariz. - 1 7 15 40 63 94 46 259 319 37 57

Utah 1 1 5 6 17 18 3 4 51 48 5 15

Nev. 2 6 8 6 12 19 19 31 128 115 7 17

PACIFIC 112 114 386 299 646 619 518 631 4,762 4,845 334 408

Wash. 18 10 21 23 101 126 6 17 231 278 6 15

Oreg. 19 20 23 21 122 117 12 22 173 156 5 4

Calif. 74 84 329 238 407 356 496 590 4,097 4,137 314 382

Alaska - - 3 5 10 15 - 2 70 81 9 7

Hawaii 1 - 10 12 6 5 4 - 191 193 - -

Guam - - - 2 1 3 3 8 35 113 - -

P.R. - - 2 1 5 24 122 284 84 263 43 39

V.I. - - - 2 - - - - - - - -

Amer. Samoa - - - - - - - - - 5 - -

C.N.M.I. - - - 1 - - 1 9 - 41 - -

N: Not notifiable U: Unavailable -: no reported cases

Reporting Area

Lyme

Disease Malaria

Meningococcal

Disease

Syphilis

(Primary & Secondary) Tuberculosis Rabies, Animal

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995

Vol. 45 / Nos. 51 & 52 MMWR 1139
TABLE III. Provisional cases of selected notifiable diseases preventable by vaccination,

United States, weeks ending December 28, 1996,

and December 30, 1995 (52nd Week)

UNITED STATES 1,065 1,180 29,024 31,582 9,994 10,805 1 438 - 50

NEW ENGLAND 90 46 428 333 206 252 - 14 - 1

Maine 1 3 26 30 2 12 - - - -

N.H. 11 13 27 13 21 23 - - - -

Vt. 2 2 12 8 11 7 - 1 - 1

Mass. 74 16 203 161 75 114 - 12 - -

R.I. 2 5 25 35 12 10 - - - -

Conn. - 7 135 86 85 86 U 1 U -

MID. ATLANTIC 147 177 1,858 2,091 1,411 1,599 - 23 - 5

Upstate N.Y. 12 45 429 523 335 414 - - - -

N.Y. City 40 36 600 1,008 566 524 - 9 - 3

N.J. 66 32 344 312 247 368 - 3 - -

Pa. 29 64 485 248 263 293 - 11 - 2

E.N. CENTRAL 172 190 2,435 3,160 1,014 1,130 - 6 - 8

Ohio 95 99 785 1,760 120 116 - 2 - 4

Ind. 14 22 357 189 130 241 U - U -

Ill. 39 48 621 663 268 293 - 2 - 1

Mich. 12 18 500 364 421 398 - - - 3

Wis. 12 3 172 184 75 82 - 2 - -

W.N. CENTRAL 55 94 2,643 1,992 569 675 - 20 - 3

Minn. 35 56 149 198 71 93 - 16 - 2

Iowa 7 3 348 107 96 46 - - - 1

Mo. 10 28 1,377 1,338 313 437 - 3 - -

N. Dak. - - 137 23 2 5 - - - -

S. Dak. 1 1 43 99 5 2 - - - -

Nebr. 1 3 222 65 49 39 - - - -

Kans. 1 3 367 162 33 53 - 1 - -

S. ATLANTIC 202 236 1,565 1,434 1,566 1,599 - 5 - 9

Del. 7 - 21 12 9 9 U 1 U -

Md. 64 74 256 221 297 262 - - - 2

D.C. 6 - 39 26 31 21 - 1 - -

Va. 11 28 192 238 139 118 - - - 3

W. Va. 11 11 19 24 35 53 - - - -

N.C. 26 34 204 111 337 311 - 3 - 1

S.C. 5 3 57 46 101 56 - - - -

Ga. 40 71 157 84 32 103 - - - 2

Fla. 32 15 620 672 585 666 - - - 1

E.S. CENTRAL 28 12 1,216 2,312 857 830 - 2 - -

Ky. 4 5 46 44 64 69 - - - -

Tenn. 13 - 744 1,951 488 647 U 2 U -

Ala. 10 6 211 93 74 114 - - - -

Miss. 1 1 215 224 231 U - - - -

W.S. CENTRAL 41 80 6,134 5,287 1,269 1,712 - 26 - 2

Ark. - 6 500 663 78 83 - - - -

La. 5 1 221 196 153 243 - - - -

Okla. 31 31 2,453 1,427 23 173 - - - -

Tex. 5 42 2,960 3,001 1,015 1,213 - 26 - 2

MOUNTAIN 62 122 4,530 4,346 1,160 879 - 153 - 5

Mont. - 1 120 173 17 24 - - - -

Idaho 1 6 250 353 88 102 - 1 - -

Wyo. - 11 40 110 45 33 - 1 - -

Colo. 15 16 521 509 140 138 - 4 - 3

N. Mex. 11 16 353 808 413 321 - 17 - -

Ariz. 17 30 1,758 1,363 239 121 - 8 - -

Utah 9 12 1,071 696 124 75 - 117 - 2

Nev. 9 30 417 334 94 65 - 5 - -

PACIFIC 268 223 8,215 10,627 1,942 2,129 1 189 - 17

Wash. 4 11 744 937 114 226 - 51 - -

Oreg. 32 28 835 2,723 118 129 - 10 - 1

Calif. 226 178 6,484 6,751 1,680 1,729 - 37 - 9

Alaska 3 2 46 50 18 13 - 63 - -

Hawaii 3 4 106 166 12 32 1 28 - 7

Guam - - 5 10 - 5 U - U -

P.R. - 3 141 120 386 689 - 8 - -

V.I. - - - 9 - 16 U - U -

Amer. Samoa - - - 6 - - U - U -

C.N.M.I. 10 11 1 24 5 22 U - U -

N: Not notifiable U: Unavailable -: no reported cases

*Of 276 cases among children aged <5 years, serotype was reported for 94 and of those, 30 were type b. †For imported measles, cases include only those resulting from importation from other countries.

Reporting Area

H. influenzae,

invasive

Hepatitis (viral), by type Measles (Rubeola)

A B Indigenous Imported†

Cum.

1996*

Cum.

1995

Cum.

1996

Cum.

1995

Cum.

1996

Cum.

1995 1996

Cum.

1996 1996

Cum.

1996

1140 MMWR January 3, 1997
UNITED STATES 488 309 12 658 906 174 6,467 5,137 - 210 128

NEW ENGLAND 15 13 1 4 13 80 1,586 731 - 26 52

Maine - - - - 4 - 23 47 - - -

N.H. - - 1 1 1 4 180 70 - - 1

Vt. 2 - - - - 3 241 81 - 2 -

Mass. 12 5 - 2 3 65 1,066 492 - 20 11

R.I. - 6 - 1 1 8 40 7 - - -

Conn. 1 2 U - 4 U 36 34 U 4 40

MID. ATLANTIC 28 14 2 91 134 48 786 469 - 13 16

Upstate N.Y. - 1 1 28 33 - 480 253 - 5 5

N.Y. City 12 5 - 17 17 2 57 67 - 5 8

N.J. 3 8 - 3 21 - 19 20 - 2 3

Pa. 13 - 1 43 63 46 230 129 - 1 -

E.N. CENTRAL 14 15 3 107 172 11 609 667 - 3 4

Ohio 6 2 3 52 54 10 290 175 - - -

Ind. - - U 8 10 U 94 76 U - -

Ill. 3 2 - 20 48 - 166 155 - 1 -

Mich. 3 5 - 26 60 1 54 103 - 2 4

Wis. 2 6 - 1 - - 5 158 - - -

W.N. CENTRAL 23 12 - 20 52 11 471 369 - - 1

Minn. 18 9 - 6 11 3 356 238 - - -

Iowa 1 - - 3 11 4 30 11 - - -

Mo. 3 2 - 7 25 4 58 63 - - -

N. Dak. - - - 2 1 - 1 8 - - -

S. Dak. - - - - - - 4 12 - - -

Nebr. - - - - 4 - 15 14 - - -

Kans. 1 1 - 2 - - 7 23 - - 1

S. ATLANTIC 14 19 3 112 163 7 703 388 - 100 14

Del. 1 - U - - U 27 10 U - -

Md. 2 1 1 32 41 2 263 49 - - 1

D.C. 1 - - 1 - - 5 8 - 2 -

Va. 3 - - 16 28 - 99 31 - 2 -

W. Va. - - - - - 1 7 1 - - -

N.C. 4 - - 21 42 - 131 137 - 85 1

S.C. - - - 7 13 - 49 28 - 1 -

Ga. 2 4 - 3 11 2 20 30 - - -

Fla. 1 14 2 32 28 2 102 94 - 10 12

E.S. CENTRAL 2 - - 24 20 - 198 277 - 2 1

Ky. - - - - - - 140 27 - - -

Tenn. 2 - U 3 5 U 21 209 U - 1

Ala. - - - 6 5 - 28 38 - 2 -

Miss. - - - 15 10 - 9 3 N N N

W.S. CENTRAL 28 34 - 46 66 - 127 342 - 3 8

Ark. - 2 - 1 7 - 10 59 - - -

La. - 18 - 18 15 - 11 22 - 1 -

Okla. - - - 1 1 - 19 44 - - -

Tex. 28 14 - 26 43 - 87 217 - 2 8

MOUNTAIN 158 70 - 22 33 11 473 743 - 7 5

Mont. - - - - 1 - 36 9 - - -

Idaho 1 2 - - 4 5 115 116 - 2 -

Wyo. 1 - - 1 - - 8 1 - - -

Colo. 7 26 - 3 3 5 157 149 - 3 1

N. Mex. 17 31 N N N 1 63 148 - - -

Ariz. 8 10 - 1 2 - 29 164 - 1 3

Utah 119 - - 2 11 - 24 37 - - 1

Nev. 5 1 - 15 12 - 41 119 - 1 -

PACIFIC 206 132 3 232 253 6 1,514 1,151 - 56 27

Wash. 51 20 - 21 16 - 722 491 - 2 1

Oreg. 11 1 - - - - 35 67 - 1 -

Calif. 46 109 2 178 211 6 724 531 - 50 21

Alaska 63 - - 3 12 - 4 1 - - -

Hawaii 35 2 1 30 14 - 29 61 - 3 5

Guam - - U 5 4 U 1 2 U - 1

P.R. 8 3 - 1 3 - 1 3 - - -

V.I. - - U - 3 U - - U - -

Amer. Samoa - - U - - U - - U - -

C.N.M.I. - - U - 1 U - - U - -

N: Not notifiable U: Unavailable -: no reported cases

TABLE III. (Cont’d.) Provisional cases of selected notifiable diseases preventable

by vaccination, United States, weeks ending December 28, 1996,

and December 30, 1995 (52nd Week)

Reporting Area

Measles (Rubeola), cont’d.

Total Mumps Pertussis Rubella

Cum.

1996

Cum.

1995 1996

Cum.

1996

Cum.

1995 1996

Cum.

1996

Cum.

1995 1996

Cum.

1996

Cum.

1995

Vol. 45 / Nos. 51 & 52 MMWR 1141
NEW ENGLAND 555 395 95 42 14 9 56

Boston, Mass. 149 90 32 17 5 5 17

Bridgeport, Conn. 29 23 3 3 - - 2

Cambridge, Mass. 20 18 2 - - - 1

Fall River, Mass. 20 18 2 - - - -

Hartford, Conn. 54 39 10 5 - - 1

Lowell, Mass. 26 22 4 - - - -

Lynn, Mass. 16 14 2 - - - 3

New Bedford, Mass. 31 26 4 1 - - 2

New Haven, Conn. 48 28 11 4 3 2 4

Providence, R.I. U U U U U U U

Somerville, Mass. 3 1 - 2 - - -

Springfield, Mass. 53 40 7 4 1 1 8

Waterbury, Conn. 28 22 4 1 1 - 5

Worcester, Mass. 78 54 14 5 4 1 13

MID. ATLANTIC 2,384 1,737 395 177 39 36 168

Albany, N.Y. 61 45 7 4 2 3 1

Allentown, Pa. 19 19 - - - - 2

Buffalo, N.Y. 75 58 12 1 2 2 9

Camden, N.J. 27 18 7 - 1 1 1

Elizabeth, N.J. 23 15 8 - - - 1

Erie, Pa.§ 55 46 7 1 - 1 7

Jersey City, N.J. 61 42 12 6 - 1 1

New York City, N.Y. 1,250 895 210 109 17 19 73

Newark, N.J. 39 17 13 7 2 - 4

Paterson, N.J. 17 13 2 2 - - 3

Philadelphia, Pa. 401 285 73 29 10 4 22

Pittsburgh, Pa.§ 49 38 9 1 - 1 6

Reading, Pa. 15 13 1 - 1 - 6

Rochester, N.Y. 119 100 9 7 2 1 15

Schenectady, N.Y. 27 18 8 1 - - 2

Scranton, Pa.§ 32 26 6 - - - 3

Syracuse, N.Y. 76 59 10 6 1 - 9

Trenton, N.J. 15 12 - - - 3 2

Utica, N.Y. 23 18 1 3 1 - 1

Yonkers, N.Y. U U U U U U U

E.N. CENTRAL 1,077 813 166 67 19 11 97

Akron, Ohio 35 21 8 2 2 2 -

Canton, Ohio 19 13 6 - - - 3

Chicago, Ill. U U U U U U U

Cincinnati, Ohio 80 62 12 3 3 - 10

Cleveland, Ohio 125 87 26 10 1 1 3

Columbus, Ohio 130 92 23 8 3 4 18

Dayton, Ohio 100 78 13 8 - 1 11

Detroit, Mich. U U U U U U U

Evansville, Ind. 39 36 1 1 - 1 1

Fort Wayne, Ind. 38 25 9 4 - - 2

Gary, Ind. U U U U U U U

Grand Rapids, Mich. 92 70 10 7 4 1 13

Indianapolis, Ind. 108 85 17 4 2 - 5

Madison, Wis. U U U U U U U

Milwaukee, Wis. 71 55 10 6 - - 7

Peoria, Ill. 41 36 5 - - - 7

Rockford, Ill. 41 31 3 6 1 - 3

South Bend, Ind. 39 33 4 1 1 - 5

Toledo, Ohio 53 42 7 3 1 - 8

Youngstown, Ohio 66 47 12 4 1 1 1

W.N. CENTRAL 698 504 110 36 13 14 38

Des Moines, Iowa 70 50 14 4 1 1 9

Duluth, Minn. 29 16 8 3 1 1 -

Kansas City, Kans. 29 23 4 1 1 - 1

Kansas City, Mo. 122 71 19 9 - 2 6

Lincoln, Nebr. 34 30 3 - 1 - 6

Minneapolis, Minn. 108 85 17 3 1 2 5

Omaha, Nebr. 75 55 10 6 1 3 5

St. Louis, Mo. 114 82 18 7 5 2 -

St. Paul, Minn. 43 33 6 1 1 2 2

Wichita, Kans. 74 59 11 2 1 1 4

S. ATLANTIC 992 615 208 120 24 25 63

Atlanta, Ga. 99 54 25 16 3 1 6

Baltimore, Md. 189 118 37 28 3 3 27

Charlotte, N.C. U U U U U U U

Jacksonville, Fla. 108 72 21 11 2 2 2

Miami, Fla. 95 57 23 11 3 1 -

Norfolk, Va. 32 18 6 3 - 5 1

Richmond, Va. 51 38 8 2 2 1 6

Savannah, Ga. 51 38 11 1 1 - 4

St. Petersburg, Fla. 38 26 6 3 1 2 2

Tampa, Fla. 118 78 24 11 2 3 7

Washington, D.C. 199 110 47 28 7 7 8

Wilmington, Del. 12 6 - 6 - - -

E.S. CENTRAL 480 310 106 39 15 9 33

Birmingham, Ala. 83 54 17 6 5 - -

Chattanooga, Tenn. 50 34 11 3 1 1 3

Knoxville, Tenn. 100 69 21 7 3 - 15

Lexington, Ky. 70 43 17 5 1 4 6

Memphis, Tenn. U U U U U U U

Mobile, Ala. 59 38 13 5 3 - -

Montgomery, Ala. 39 27 7 2 - 3 -

Nashville, Tenn. 79 45 20 11 2 1 9

W.S. CENTRAL 886 574 167 82 37 26 61

Austin, Tex. 38 28 6 2 1 1 2

Baton Rouge, La. 39 30 2 6 - 1 2

Corpus Christi, Tex. 35 23 10 - 1 1 3

Dallas, Tex. 138 70 28 19 11 10 2

El Paso, Tex. 34 24 8 2 - - 4

Ft. Worth, Tex. 82 50 17 9 6 - 2

Houston, Tex. 210 132 44 25 6 3 29

Little Rock, Ark. 61 38 8 6 6 3 4

New Orleans, La. U U U U U U U

San Antonio, Tex. 109 81 15 6 4 3 2

Shreveport, La. 82 57 17 5 - 3 6

Tulsa, Okla. 58 41 12 2 2 1 5

MOUNTAIN 885 625 151 62 25 21 73

Albuquerque, N.M. 85 63 13 5 2 2 8

Colo. Springs, Colo. U U U U U U U

Denver, Colo. 153 102 34 12 2 3 17

Las Vegas, Nev. 179 131 35 7 3 2 14

Ogden, Utah 29 26 1 1 - 1 1

Phoenix, Ariz. 192 121 35 17 12 7 12

Pueblo, Colo. 35 31 3 1 - - 5

Salt Lake City, Utah 100 72 8 12 4 4 5

Tucson, Ariz. 112 79 22 7 2 2 11

PACIFIC 1,441 1,031 253 104 32 21 130

Berkeley, Calif. 18 16 2 - - - -

Fresno, Calif. 61 36 13 5 4 3 6

Glendale, Calif. 5 3 1 1 - - -

Honolulu, Hawaii 50 39 6 3 1 1 6

Long Beach, Calif. 74 58 11 5 - - 9

Los Angeles, Calif. 191 109 44 27 5 6 2

Pasadena, Calif. 25 19 5 - 1 - 2

Portland, Oreg. 102 77 12 6 4 3 4

Sacramento, Calif. 177 128 34 9 4 2 17

San Diego, Calif. 140 95 28 12 2 3 16

San Francisco, Calif. 114 84 21 9 - - 19

San Jose, Calif. 199 147 34 13 5 - 32

Santa Cruz, Calif. 28 25 2 - 1 - 4

Seattle, Wash. 139 103 20 11 4 1 9

Spokane, Wash. 45 37 6 - 1 1 1

Tacoma, Wash. 73 55 14 3 - 1 3

TOTAL 9,398¶ 6,604 1,651 729 218 172 719

Reporting Area >65 45-64 25-44 1-24 <1

P&I†

All Total

Ages

All Causes, By Age (Years)

Reporting Area

P&I†

All Total

Ages

All Causes, By Age (Years)

>65 45-64 25-44 1-24 <1

U: Unavailable -: no reported cases

*Mortality data in this table are voluntarily reported from 121 cities in the United States, most of which have populations of 100,000 or

more. A death is reported by the place of its occurrence and by the week that the death certificate was filed. Fetal deaths are not

included.

†Pneumonia and influenza.

§Because of changes in reporting methods in these 3 Pennsylvania cities, these numbers are partial counts for the current week. Complete

counts will be available in 4 to 6 weeks.

¶Total includes unknown ages.

TABLE IV. Deaths in 121 U.S. cities,* week ending

December 28, 1996 (52nd Week)

1142 MMWR January 3, 1997
Contributors to the Production of the MMWR (Weekly)

Weekly Notifiable Disease Morbidity Data and 121 Cities Mortality Data

Denise Koo, M.D., M.P.H.

Deborah A. Adams

Timothy M. Copeland

Patsy A. Hall

Carol M. Knowles

Sarah H. Landis

Myra A. Montalbano

Desktop Publishing and Graphics Support

Morie M. Higgins

Peter M. Jenkins

Vol. 45 / Nos. 51 & 52 MMWR 1143
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control

and Prevention (CDC) and is available free of charge in electronic format and on a paid subscription basis

for paper copy. To receive an electronic copy on Friday of each week, send an e-mail message to

lists@list.cdc.gov. The body content should read subscribe mmwr-toc. Electronic copy also is available

from CDC’s World-Wide Web server at http://www.cdc.gov/ or from CDC’s file transfer protocol server at

ftp.cdc.gov. To subscribe for paper copy, contact Superintendent of Documents, U.S. Government Printing

Office, Washington, DC 20402; telephone (202) 512-1800.

Data in the weekly MMWR are provisional, based on weekly reports to CDC by state health departments.

The reporting week concludes at close of business on Friday; compiled data on a national basis are officially

released to the public on the following Friday. Address inquiries about the MMWR Series, including material

to be considered for publication, to: Editor, MMWR Series, Mailstop C-08, CDC, 1600 Clifton Rd., N.E., Atlanta,

GA 30333; telephone (404) 332-4555.

All material in the MMWR Series is in the public domain and may be used and reprinted without

permission; citation as to source, however, is appreciated.

Director, Centers for Disease Control 

and Prevention

David Satcher, M.D., Ph.D.

Deputy Director, Centers for Disease Control

and Prevention

Claire V. Broome, M.D.

Director, Epidemiology Program Office

Stephen B. Thacker, M.D., M.Sc.

Editor, MMWR Series

Richard A. Goodman, M.D., M.P.H.

Managing Editor, MMWR (weekly)

Karen L. Foster, M.A.

Writers-Editors, MMWR (weekly)

David C. Johnson

Darlene D. Rumph Person

Caran R. Wilbanks

Editorial Assistant, MMWR (weekly)

Teresa F. Rutledge

✩U.S. Government Printing Office: 1997-532-228/47049 Region IV

1144 MMWR January 3, 1997